The Aceto Corp. headquarters in Port Washington, seen on Oct....

The Aceto Corp. headquarters in Port Washington, seen on Oct. 21, 2011. Credit: Barry Sloan

Aceto Corp. has begun selling a generic drug to treat ear infections.

The Port Washington-based manufacturer of drugs and chemicals recently launched Fluocinolone Acetonide OTIC Oil 0.01%, a generic version of DermOtic from drugmaker Hill Dermaceuticals Inc. The oils are used for chronic eczematous external otitis, an inflammation of the ear canal caused by a bacterial infection.

Only 25¢ for 5 months

Unlimited Digital Access. Cancel anytime.

Already a subscriber?

Aceto Corp. has begun selling a generic drug to treat ear infections.

The Port Washington-based manufacturer of drugs and chemicals recently launched Fluocinolone Acetonide OTIC Oil 0.01%, a generic version of DermOtic from drugmaker Hill Dermaceuticals Inc. The oils are used for chronic eczematous external otitis, an inflammation of the ear canal caused by a bacterial infection.

The product will be handled by the company’s Rising Pharmaceuticals Inc. subsidiary in New Jersey, officials said earlier this month.

U.S. sales of existing versions of the drug were $30 million in the 12 months ended July 31, according to the health care research firm IMS Health.

As we remember those we lost on 9/11, we're looking at the ongoing battle to secure long term protection for first responders and the latest twists and turns in the cases of the accused terrorists.

Remembering 9/11: Where things stand now As we remember those we lost on 9/11, we're looking at the ongoing battle to secure long term protection for first responders and the latest twists and turns in the cases of the accused terrorists.